State of New Jersey Common Pension Fund D’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.9M Sell
33,596
-1,701
-5% -$1.16M 0.07% 225
2026
Q1
$27.3M Sell
35,297
-219
-0.6% -$168K 0.11% 160
2025
Q4
$27.4M Sell
35,516
-1,653
-4% -$1.12M 0.1% 155
2025
Q3
$20.9M Buy
37,169
+946
+3% +$535K 0.08% 209
2025
Q2
$19M Sell
36,223
-23
-0.1% -$12.8K 0.07% 218
2025
Q1
$23M Sell
36,246
-3,571
-9% -$2.46M 0.1% 171
2024
Q4
$28.4M Sell
39,817
-22
-0.1% -$18.5K 0.11% 154
2024
Q3
$41.9M Hold
39,839
0.17% 104
2024
Q2
$41.9M Sell
39,839
-21,431
-35% -$20.8M 0.18% 102
2024
Q1
$59M Hold
61,270
0.18% 112
2023
Q4
$53.8M Sell
61,270
-156
-0.3% -$128K 0.18% 111
2023
Q3
$50.6M Sell
61,426
-1,774
-3% -$1.39M 0.18% 109
2023
Q2
$45.4M Hold
63,200
0.15% 125
2023
Q1
$51.9M Hold
63,200
0.19% 110
2022
Q4
$45.6M Sell
63,200
-291
-0.5% -$215K 0.17% 119
2022
Q3
$43.7M Buy
63,491
+1,112
+2% +$700K 0.18% 105
2022
Q2
$36.9M Hold
62,379
0.14% 139
2022
Q1
$43.6M Buy
62,379
+480
+0.8% +$304K 0.14% 132
2021
Q4
$39.1M Sell
61,899
-367
-0.6% -$226K 0.11% 159
2021
Q3
$37.7M Sell
62,266
-140
-0.2% -$86.9K 0.12% 158
2021
Q2
$34.9M Sell
62,406
-484
-0.8% -$245K 0.11% 169
2021
Q1
$29.8M Sell
62,890
-905
-1% -$441K 0.1% 181
2020
Q4
$30.8M Sell
63,795
-3,247
-5% -$1.75M 0.11% 168
2020
Q3
$37.5M Buy
67,042
+6,968
+12% +$4.22M 0.15% 129
2020
Q2
$37.5M Buy
60,074
+117
+0.2% +$66.4K 0.16% 123
2020
Q1
$29.3M Hold
59,957
0.14% 143
2019
Q4
$22.5M Sell
59,957
-3,243
-5% -$1.09M 0.08% 229
2019
Q3
$17.5M Buy
63,200
+55,200
+690% +$16.3M 0.07% 289
2019
Q2
$2.5M Hold
8,000
0.01% 706
2019
Q1
$3.29M Hold
8,000
0.01% 650
2018
Q4
$2.99M Hold
8,000
0.01% 639
2018
Q3
$3.23M Hold
8,000
0.01% 669
2018
Q2
$2.76M Hold
8,000
0.01% 718
2018
Q1
$2.75M Buy
8,000
+5,000
+167% +$1.74M 0.01% 712
2017
Q4
$1.13M Hold
3,000
﹤0.01% 836
2017
Q3
$1.34M Buy
+3,000
New +$1.43M 0.01% 811

Other funds holding REGN

State of New Jersey Common Pension Fund D's REGN Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Regeneron Pharmaceuticals (REGN) stake by 4.8% in Q2 2026, selling an estimated $1.16M and leaving 33,596 shares worth $20.9M. The position accounts for 0.07% of the portfolio, ranked #225.

State of New Jersey Common Pension Fund D first reported a position in REGN in Q3 2017 and has held it in 36 quarters since. The position peaked at $59M in Q1 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 33,596 shares of Regeneron Pharmaceuticals worth $20.9M as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 1,701 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.16M.
  • Regeneron Pharmaceuticals made up 0.07% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #225 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Regeneron Pharmaceuticals in Q3 2017 and has held it in 36 quarters since.
  • State of New Jersey Common Pension Fund D's Regeneron Pharmaceuticals position peaked at $59M in Q1 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.